发明名称 Use of cxcl6 in the preparation of a medicament for the promotion of cartilage and/or bone formation
摘要 <p>The present invention disclosed the expression of CXCL6 by cells which are able to form stable cartilage. The invention describes the use of these cells and of CXCL6 to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects. The invention further describes the use of chemokines in the modulation of progenitor cell differentiation.</p>
申请公布号 IL173544(A) 申请公布日期 2013.12.31
申请号 IL20060173544 申请日期 2006.02.05
申请人 TIGENIX N.V. 发明人
分类号 A61K;A61K38/19;A61P;A61P19/00 主分类号 A61K
代理机构 代理人
主权项
地址